Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.20
+0.23 (2.31%)
At close: May 29, 2026, 4:00 PM EDT
10.30
+0.10 (0.98%)
After-hours: May 29, 2026, 7:29 PM EDT
Kura Oncology Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Kura Oncology stock has a consensus rating of "Strong Buy" and an average price target of $31.17. The average 1-year stock price forecast is 205.59% higher than the current stock price, while the lowest is $15 (+47.06%) and the highest is $76 (+645.10%).
Price Target: $31.17 (+205.59%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kura Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 12 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $30 | Buy | Maintains | $30 | +194.12% | May 26, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $28 | Buy | Maintains | $28 | +174.51% | May 26, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $28 | Buy | Maintains | $28 | +174.51% | May 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +292.16% | May 22, 2026 |
| Wedbush | Wedbush | Buy Maintains $36 | Buy | Maintains | $36 | +252.94% | May 13, 2026 |
Financial Forecast
Revenue This Year
94.01M
from 67.48M
Increased by 39.32%
Revenue Next Year
192.07M
from 94.01M
Increased by 104.30%
EPS This Year
-3.58
from -3.18
EPS Next Year
-2.65
from -3.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 119.7M | 296.8M | ||||||
| Avg | 94.0M | 192.1M | ||||||
| Low | 73.1M | 114.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 77.4% | 215.7% | ||||||
| Avg | 39.3% | 104.3% | ||||||
| Low | 8.3% | 22.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.49 | -1.71 | ||||||
| Avg | -3.58 | -2.65 | ||||||
| Low | -3.68 | -3.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.